Document:

onvo-ex101_11.htm

 

 

Exhibit 10.1

 

 

 

	
 
	

	
 
	
 
	
 

	
 
	
 
	
Organovo, Inc.

440 Stevens Avenue, Suite 200

Solana Beach, CA  92075

 

December 28, 2020

 

Dear Tom,

 

On behalf of Organovo Inc., (“Organovo”) it is our great pleasure to extend you an offer of employment as General Counsel and Corporate Secretary of Organovo and Organovo Holdings, Inc. (the “Company”), contingent on approval by the Company’s Board of Directors (the “Board”), reporting to Keith Murphy, Principal Executive Officer. In making this offer, we are expressing our enthusiastic support for the skills and commitment you will bring to our exciting team. We are pleased to offer you the following. 

 

We are pleased to offer you the following:

 

Salary: Your base salary for this exempt position will be $360,000 per year, paid bi-weekly and subject to deductions and income tax withholding as required by law or the policies of the Company. Future increases will be considered by the Compensation Committee in its review or executive compensation. You will be considered an exempt employee. Any future increases will be awarded on an annual basis based upon performance. 

 

Bonus: You are eligible to participate in Organovo’s Bonus Plan, with a target incentive of 40% of the portion  of your annual base salary actually paid by Organovo; however, the actual bonus received will be based upon the Company’s performance and the achievement of both corporate and individual goals each fiscal year. Bonus payments will be subject to required deductions and withholdings and are calculated as a proportion of annual W-2 earnings. The Company’s Compensation Committee shall have the sole discretion to determine whether you have earned any bonus set forth in this paragraph, and if so, the amount of any such bonus. 

 

At Organovo, our salary merit increases, potential bonus amounts, and annual equity grants are based upon the assumption that an employee has provided services to the Company for the entire fiscal year. Therefore, if you join Organovo at any time between April 1st and March 31st of any fiscal year, your potential salary merit increase, potential bonus, and equity grants, if any are awarded, will be prorated for the actual amount of service you provide during the fiscal year. If you join Organovo in the fourth quarter of Organovo’s fiscal year (between Jan 1st and March 31st), you will not be eligible to participate in the annual performance review cycle for that fiscal year, and will not receive any salary increase, bonus, or equity increases in that fiscal year.

 

 

 

 

Equity Package: In addition, subject to approval by the Board's Compensation Committee after your start date, we are pleased to offer you a Stock Option Award (the "Stock Option"). The Stock Option will be exercisable for 35,000 shares of the Company's common stock (the "Option Shares") (equal to approximately 0.3% of the Company's outstanding common stock as of the date of grant. The exercise price for the Option Shares will be set at the closing market price of the Company's common stock on the Nasdaq Stock Market on the date the Compensation Committee approves the grant.  One-fourth (1/4th)  of the Option Shares will vest one year from your start date at the Company (the "Vesting Commencement  Date"), and the remaining Option Shares will vest on a quarterly basis thereafter over a period totaling four years from the Vesting Commencement Date, subject to your continuous service through such date. 

 

Severance and Change in Control: You are eligible to participate in the Company's Severance and Change in Control Arrangement (the "Arrangement”).  In the event of a Change in Control, you will be eligible for 12 months of severance (contingent upon you signing a severance, release and waiver agreement) after you have worked at least 6 months for Organovo. In the event your employment is terminated, you are eligible for 9 months of severance. This Arrangement has been approved by the Compensation Committee of the Board and may be modified by the Compensation Committee of the Board in the future.

 

Benefits: Organovo provides eligibility for group medical, dental and vision insurance plans for employees and their dependents.   

 

Should you be eligible for and accept Organovo benefits, they become effective on the first of the month following date of hire. Organovo also has a 401(k) retirement plan with a company specified match, and a Section 125 plan allowing employees to have a health care spending account and a dependent care spending account. These latter items allow employees to make contributions with pre-tax dollars. Finally, Organovo also offers long term disability, accidental death & dismemberment and life insurance (at one times your annual base salary) fully paid for by the Company. 

 

Time Off: Total Personal Time Off (“PTO”) is accrued at a rate of 5.24 hours per pay period for new hires, which is equivalent to seventeen (17) days for a full-time employee on an annual basis. PTO will increase over time per company policy. We also offer 8 paid holidays.

 

Start Date: Should you find our offer attractive, we would like your start date to be January 1, 2021.

 

This employment offer is contingent upon you signing our Employee Confidentiality Agreement providing legally required evidence of your right to work in the United States as well as Organovo’s successful completion of your references and background check. In consideration of your employment, you also agree to conform to the policies and standards of the Company. 

 

Your employment will be “at-will” and either party may terminate the relationship at any time with or without cause and with or without notice. 

 

By your signature below, you acknowledge that you will be an exempt employee and this offer letter supersedes any prior Offer Letters provided to you by the Company, and represents the entire agreement between you and Organovo, and that no verbal or written agreements, 

 

 

 

promises or representations that are not specifically stated in this offer, are or will be binding upon Organovo. Any additions or modifications of these terms must be in writing and signed by you and Organovo’s General Counsel. On the first day of employment, you will be required to provide the Company with the legally required proof of your identity and authorization to work in the United States. Also, as a new hire, your performance will be reviewed after 30, 60, and 90 days, and after each time your continued employment will be evaluated. This trial period does not in any way modify the at-will status of your employment relationship with the company.

 

We hope that you'll accept this offer and look forward to welcoming you aboard! Please feel free to contact me if you have any questions. 

 

Sincerely, 

Chris Heberlig

President & Chief Financial Officer 

 

 

 

 

 

To accept this job offer:

 

	
 
	
•
	
Sign and date this job offer letter where indicated below.

	
 
	
•
	
Return a signed and dated document back within 5 days of the date of this letter. A copy of the document should be retained for your records. The document should be scanned and returned electronically to HR@organovo.com.

 

Accept Job Offer

By signing and dating this offer letter, I, Tom Jurgensen, accept this offer of employment from Organovo, Inc.

 

	
Signature:
	
 
	
 
	
Date:Exhibit 10.1

 

Execution Version

 

STOCKHOLDER SUPPORT AGREEMENT

 

This Stockholder Support
Agreement (this “Agreement”) is made and entered into as of February 7, 2021, by and among Tortoise Acquisition
Corp. II, a Cayman Islands exempted company (“Acquiror”) and the undersigned stockholders (each, a “Written
Consent Party” and, collectively, the “Written Consent Parties”) of Volta Industries, Inc.,
a Delaware corporation (the “Company”). Capitalized terms used but not otherwise defined herein shall
have the respective meanings ascribed to such terms in the Business Combination Agreement (as defined below).

 

RECITALS

 

WHEREAS, on February
7, 2021, Acquiror, SNPR Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned Subsidiary of Acquiror (“First
Merger Sub”), SNPR Merger Sub II, LLC, a Delaware limited liability company (“Second Merger Sub”
and, together with First Merger Sub, the “Merger Subs”), and the Company, entered into a Business Combination
Agreement and Plan of Reorganization (the “Business Combination Agreement”), pursuant to which (a) First
Merger Sub will merge with and into the Company (the “First Merger”), with the Company surviving the
First Merger as a wholly owned subsidiary of Acquiror; and (b) as soon as practicable, but in any event within 3 days following
the First Merger and as part of the same overall transaction as the First Merger, the surviving corporation of the First Merger
will merge with and into the Second Merger Sub (the “Second Merger” and, together with the First Merger,
the “Mergers”), with Second Merger Sub being the surviving entity of the Second Merger;

 

WHEREAS, each Written
Consent Party agrees to enter into this Agreement with respect to all Company Securities (as defined below) that such Written Consent
Party now or hereafter owns, beneficially (as defined in Rule 13d-3 under the Exchange Act) or of record;

 

WHEREAS, each Written
Consent Party is the beneficial and/or record owner of, and has the sole right to vote or direct the voting of, such number of
shares of Company Class A Common Stock and Company Preferred Stock (collectively, “Company Stock”) as
are set forth on Schedule A attached hereto opposite the name of such Written Consent Party;

 

WHEREAS, each of Acquiror
and each Written Consent Party has determined that it is in its best interests to enter into this Agreement;

 

WHEREAS, each Written
Consent Party understands and acknowledges that Acquiror is entering into the Business Combination Agreement in reliance upon such
Written Consent Party’s execution and delivery of this Agreement; and

 

WHEREAS, following
the date hereof, Acquiror intends to file with the SEC a registration statement on Form S-4 in connection with the matters set
forth in Section 7.02(a) of the Business Combination Agreement (the “Registration Statement”).

 

     

     

    

 

NOW, THEREFORE, in
consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth below and for
other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending
to be legally bound, do hereby agree as follows:

 

1. Definitions.
When used in this Agreement, the following terms in all of their tenses, cases and correlative forms shall have the meanings assigned
to them in this Section 1 or elsewhere in this Agreement. 

 

“Affiliate”
of a specified person means a Person who, directly or indirectly through one or more intermediaries, controls, is controlled by,
or is under common control with, such specified Person (provided that if a Written Consent Party is a venture capital, private
equity, growth equity, angel fund or similar funding vehicle, no portfolio company of such Written Consent Party will be deemed
an Affiliate of such Written Consent Party, and the Company shall not be deemed to be an Affiliate of any Written Consent Party
for purposes of this Agreement).

 

“Company
Securities” means, collectively, any Company Common Stock, Company Preferred Stock, Company Options, Company Non-Plan
Options, Company Restricted Stock, Company Warrants, any securities convertible into or exchangeable for any of the foregoing,
and any interest in or right to acquire any of the foregoing, whether now owned or hereafter acquired by any Written Consent Party
hereto.

 

“Expiration
Time” shall mean the earlier to occur of (a) the Effective Time, (b) such date as the Business Combination
Agreement shall be validly terminated in accordance with Article IX thereof and (c) with respect to each Written Consent Party
and Acquiror, the effective date of a written agreement between Acquiror and such Written Consent Party terminating this Agreement.

 

“Person”
means an individual, corporation, partnership, limited partnership, limited liability company, syndicate, person (including a “person”
as defined in Section 13(d)(3) of the Exchange Act), trust, association or entity or government, political subdivision, agency
or instrumentality of a government.

 

“Transfer”
shall mean any direct or indirect sale, assignment, encumbrance, pledge, hypothecation, disposition, loan or other transfer, or
entry into any agreement with respect to any sale, assignment, encumbrance, pledge, hypothecation, disposition, loan or other transfer,
excluding entry into this Agreement and the Business Combination Agreement and the consummation of the transactions contemplated
hereby and thereby.

 

    2

     

    

 

2. Agreement
to Retain the Company Securities.

 

2.1 No
Transfer of Company Securities. Until the Expiration Time, each Written Consent Party agrees not to, other than as expressly
required by the Business Combination Agreement, (a) Transfer any Company Securities or (b) deposit any Company Securities
into a voting trust or enter into a voting agreement or any similar agreement, arrangement or understanding with respect to Company
Securities or grant any proxy (except as otherwise provided herein), consent or power of attorney with respect thereto (other than
pursuant to this Agreement) (it being understood that the fact that certain Company Securities already may be subject to the Company
Voting Agreement or any other agreement set forth in Section 7.17 of the Company Disclosure Schedule shall not be deemed a violation
of this Section 2.1 or Section 3.1 below); provided, that any Written Consent Party may Transfer any
such Company Securities to any Affiliate of such Written Consent Party or to another stockholder of the Company that is a party
to this Agreement and bound by the terms and obligations hereof, or if such Written Consent Party is a natural person, to immediate
family or a trust for the benefit of immediate family for estate planning purposes, if, and only if, the transferee of such Company
Securities evidences in a writing reasonably satisfactory to Acquiror such transferee’s agreement to be bound by and subject
to the terms and provisions hereof to the same effect as such Written Consent Party.

 

2.2 Additional
Company Securities. Until the Expiration Time, each Written Consent Party agrees that any Company Securities that such Written
Consent Party purchases or otherwise hereinafter acquires or with respect to which such Written Consent Party otherwise acquires
sole or shared voting power after the execution of this Agreement and prior to the Expiration Time shall be subject to the terms
and conditions of this Agreement to the same extent as if they were owned by such Written Consent Party as of the date hereof.

 

2.3 Unpermitted
Transfers. Any Transfer or attempted Transfer of any Company Securities in violation of this Section 2 shall, to
the fullest extent permitted by applicable Law, be null and void ab initio.

 

3. Agreement
to Consent and Approve.

 

3.1 Hereafter
until the Expiration Time, each Written Consent Party agrees that, within forty-eight (48) hours of the Registration Statement
being declared effective by the SEC and except as otherwise agreed in writing with Acquiror, such Written Consent Party shall execute
and deliver a written consent substantially in the form attached as Exhibit E to the Business Combination Agreement (the “Stockholder
Written Consent”), which consent shall approve (i) the Business Combination Agreement, the Mergers and the other
Transactions and (ii) the termination of the agreements set forth in Section 7.17 of the Company Disclosure Schedule. Following
such execution and delivery, each Written Consent Party hereby agrees that it will not revoke, withdraw or repudiate the Stockholder
Written Consent. The Stockholder Written Consent shall be coupled with an interest and, prior to the Expiration Time, shall be
irrevocable.

 

Hereafter until the Expiration
Time, and subject to Section 2 hereof, no Written Consent Party shall enter into any tender or voting agreement, or
any similar agreement, arrangement or understanding, or grant a proxy or power of attorney, with respect to the Company Securities
that is inconsistent with this Agreement or otherwise take any other action with respect to the Company Securities that would prevent,
materially restrict, materially limit or materially interfere with the performance of such Written Consent Party’s obligations
hereunder or the consummation of the transactions contemplated hereby.

 

3.2 Hereafter
until the Expiration Time, at any meeting of the stockholders of the Company, or at any postponement or adjournment thereof, called
to seek the affirmative vote of the holders of the outstanding shares of Company Stock to adopt the Business Combination Agreement,
or approve the Mergers and the other Transactions, or in any other circumstances upon which a vote, consent or other approval (including
the Stockholder Written Consent) with respect to the Business Combination Agreement, the Mergers or the other Transactions is sought,
each Written Consent Party shall vote (or cause to be voted) all shares of Company Stock currently or hereinafter owned by such
Written Consent Party in favor of the foregoing.

 

    3

     

    

 

3.3 Hereafter
until the Expiration Time, at any meeting of the stockholders of the Company or at any postponement or adjournment thereof or in
any other circumstances upon which a Written Consent Party’s vote, consent or other approval (including by written consent)
is sought, such Written Consent Party shall vote (or cause to be voted) all Company Securities (to the extent such Company Securities
are then entitled to vote thereon), currently or hereinafter owned by such Written Consent Party against and withhold consent with
respect to any Alternative Transaction (as defined below). No Written Consent Party shall commit or agree to take any action inconsistent
with the foregoing that would be effective prior to the Expiration Time. Hereafter until the Expiration Time, in connection with
any document or other instrument pursuant to which each Written Consent Party is asked to approve or consent to the Transactions,
each Written Consent Party shall execute such document or other instrument and otherwise take such other steps as are necessary
to effect the Transactions.

 

4. Additional
Agreements.

 

4.1 Litigation.
Each Written Consent Party agrees not to commence, join in, facilitate, assist or encourage, and agrees to take all actions necessary
to opt out of any class in any class action with respect to, any claim, derivative or otherwise, against Acquiror, First Merger
Sub, Second Merger Sub, the Company or any of their respective successors, directors or officers (a) challenging the validity
of, or seeking to enjoin the operation of, any provision of this Agreement or the Business Combination Agreement or (b) alleging
a breach of any fiduciary duty of any Person in connection with the evaluation, negotiation or entry into this Agreement or the
Business Combination Agreement.

 

4.2 Waiver
of Certain Rights. Each Written Consent Party hereby waives any requirement for notice with respect to the Transactions under
any agreements with the Company.

 

4.3 Confidentiality.
Until the Expiration Time, each Written Consent Party will and will cause its Affiliates to keep confidential and not disclose
any non-public information relating to Acquiror or the Company or any of their respective subsidiaries, including the existence
or terms of, or transactions contemplated by, this Agreement, the Business Combination Agreement or the other Transaction Documents,
except to the extent that such information (i) was, is or becomes generally available to the public after the date hereof (including
by virtue of any public filings to be made by any parties to the Business Combination Agreement as are required by the federal
securities law in connection with the Registration Statement or a Current Report on Form 8-K), other than as a result of a disclosure
by such Written Consent Party in breach of this Section 4.3, (ii) is, was or becomes available to such Written Consent Party
on a non-confidential basis from a source other than Acquiror or the Company; provided that, to the knowledge of such Written
Consent Party, such information is not subject to a legal, fiduciary or contractual obligation of confidentiality or secrecy to
Acquiror or the Company, or (iii) is or was independently developed by such Written Consent Party after the date hereof without
use of, or reference to any non-public information of Acquiror or the Company. Notwithstanding the foregoing, such information
may be disclosed to the extent required to be disclosed in a judicial or administrative proceeding, or otherwise required to be
disclosed by applicable Law (including complying with any oral or written questions, interrogatories, requests for information
or documents, subpoena, civil investigative demand or similar process to which such disclosing party is subject), provided that
such Written Consent Party gives Acquiror or the Company, as applicable, prompt notice of such request(s) or requirement(s), to
the extent practicable (and not prohibited by Law), so that the Acquiror or the Company may seek, at its own expense, an appropriate
protective order or similar relief (and such Written Consent Party shall reasonably cooperate with such efforts, it being understood
that such obligation to reasonably cooperate does not require a Written Consent Party to itself commence litigation regarding such
protective order or similar relief).

 

    4

     

    

 

5. Representations
and Warranties of the Written Consent Parties. Each Written Consent Party hereby represents and warrants, severally and not
jointly, to Acquiror as follows:

 

5.1 Due
Authority. Such Written Consent Party has the full power and authority to execute and deliver this Agreement and perform its
obligations hereunder. If such Written Consent Party is an individual, the signature to this agreement is genuine and such Written
Consent Party has legal competence and capacity to execute the same. This Agreement has been duly and validly executed and delivered
by such Written Consent Party and, assuming due execution and delivery by the other parties hereto, constitutes a legal, valid
and binding obligation of such Written Consent Party, enforceable against such Written Consent Party in accordance with its terms,
except as limited by applicable Remedies Exceptions.

 

5.2 Ownership
of the Company Securities. As of the date hereof, such Written Consent Party is the owner of the Company Securities set forth
opposite such Written Consent Party’s name on Schedule A, free and clear of any and all Liens, options, rights
of first refusal and limitations on such Written Consent Party’s voting rights, other than transfer restrictions under applicable
securities laws or the certificate of incorporation or bylaws or any equivalent organizational documents of the Company, as applicable,
or any restrictions set forth in the Company Voting Agreement or any other agreement set forth in Section 7.17 of the Company Disclosure
Schedule. Except for any restrictions set forth in the Company Voting Agreement or any other agreement set forth in Section 7.17
of the Company Disclosure Schedule, such Written Consent Party has sole voting power (including the right to control such vote
as contemplated herein), power of disposition and power to issue instructions with respect to all Company Securities currently
owned by such Written Consent Party, and the power to agree to all of the matters applicable to such Written Consent Party set
forth in this Agreement. As of the date hereof, such Written Consent Party does not own any Company Securities other than the Company
Securities set forth opposite such Written Consent Party’s name on Schedule A. As of the date hereof, such Written
Consent Party does not own any rights to purchase or acquire any Company Securities, except for the Company Warrants and Company
Options set forth opposite such Written Consent Party’s name on Schedule A.

 

    5

     

    

 

5.3 No
Conflict; Consents.

 

(a) The
execution and delivery of this Agreement by such Written Consent Party does not, and the performance by such Written Consent Party
of the obligations under this Agreement and the compliance by such Written Consent Party with any provisions hereof do not and
will not: (i) conflict with or violate any Law applicable to such Written Consent Party, (ii) if such Written Consent
Party is an entity, conflict with or violate the certificate of incorporation or bylaws or any equivalent organizational documents
of the Company or such Written Consent Party, or (iii) result in any breach of, or constitute a default (or an event, which
with notice or lapse of time or both, would become a material default) under, or give to others any rights of termination, amendment,
acceleration or cancellation of, or result in the creation of a Lien on any of the Company Securities owned by such Written Consent
Party pursuant to any note, bond, mortgage, indenture, contract, agreement, lease, license, permit, franchise or other instrument
or obligation to which such Written Consent Party is a party or by which such Written Consent Party is bound, except, in the case
of clauses (i) and (iii), as would not reasonably be expected, individually or in the aggregate, to materially impair
the ability of such Written Consent Party to perform its obligations hereunder or to consummate the transactions contemplated hereby.

 

(b) The
execution and delivery of this Agreement by such Written Consent Party does not, and the performance of this Agreement by such
Written Consent Party will not, require any consent, approval, authorization or permit of, or filing or notification to, or expiration
of any waiting period by any Governmental Authority or any other Person with respect to such Written Consent Party, other than
those set forth as conditions to Closing in the Business Combination Agreement and other than those pursuant to, in compliance
with or required to be made under the Exchange Act.

 

5.4 Absence
of Litigation. As of the date hereof, there is no Action pending against, or, to the knowledge of such Written Consent Party
after reasonable inquiry, threatened against such Written Consent Party that would reasonably be expected to materially impair
the ability of such Written Consent Party to perform its obligations hereunder or to consummate the transactions contemplated hereby.

 

5.5 Absence
of Other Voting Agreement. Such Written Consent Party has not: (i) entered into any voting agreement, voting trust or
any similar agreement, arrangement or understanding, with respect to any Company Securities owned by such Written Consent Party
(other than as contemplated by this Agreement and the Company Voting Agreement or any other agreement set forth in Section 7.17
of the Company Disclosure Schedule), (ii) granted any proxy, consent or power of attorney with respect to any Company Securities
owned by such Written Consent Party (other than as contemplated by this Agreement and the Company Voting Agreement or any other
agreement set forth in Section 7.17 of the Company Disclosure Schedule) or (iii) entered into any agreement, arrangement or
understanding that would prohibit or prevent it from satisfying or would materially interfere with, or is otherwise materially
inconsistent with, its obligations pursuant to this Agreement.

 

    6

     

    

 

6. Fiduciary
Duties. The covenants and agreements set forth herein shall not prevent any designee of any Written Consent Party from serving
on the board of directors of the Company or from taking any action, subject to the provisions of the Business Combination Agreement,
while acting in such designee’s capacity as a director or officer of the Company. Each Written Consent Party is entering
into this Agreement solely in its capacity as the owner of such Written Consent Party’s Company Securities. Notwithstanding
anything in this Agreement to the contrary, (i) no Written Consent Party shall be responsible for the actions of the Company or
the board of directors of the Company (or any committee thereof), any subsidiary of the Company, or any officers (in their capacity
as such), directors (in their capacity as such), employees (in their capacity as such) and professional advisors of any of the
foregoing (collectively, the “Company Related Parties”), (ii) such Written Consent Party makes no representations
or warranties with respect to the actions of any of the Company Related Parties, and (iii) any breach by the Company of its obligations
under the Business Combination Agreement shall not be considered a breach of this Agreement (it being understood that, for the
avoidance of doubt, such Written Consent Party or his, her or its representatives (other than any such representative that is a
Company Related Party) shall remain responsible for any breach by such Written Consent Party or his, her or its representatives
of this Agreement).

 

7. Termination.
This Agreement shall terminate and be of no further force or effect at the Expiration Time. Notwithstanding the foregoing sentence,
this Section 7 and Section 10 shall survive any termination of this Agreement. Upon termination of this
Agreement, none of the parties hereto shall have any further obligations or liabilities under this Agreement; provided,
that nothing in this Section 7 shall relieve any party hereto of liability for any willful material breach of this
Agreement prior to its termination.

 

8. No
Ownership Interest. Nothing contained in this Agreement shall be deemed to vest in Acquiror any direct or indirect ownership
or incidence of ownership of or with respect to any Written Consent Party’s Company Securities. All rights, ownership and
economic benefits of and relating to each Written Consent Party’s Company Securities shall remain fully vested in and belong
to such Written Consent Party, and Acquiror shall have no authority to direct any Written Consent Party in the voting or disposition
of any of Company Securities except as otherwise provided herein.

 

9. Exclusivity.

 

9.1 From
the date of this Agreement and ending on the Expiration Time, no Written Consent Party shall, and each Written Consent Party shall
cause its Affiliates and Representatives not to, directly or indirectly, (1) enter into, solicit, initiate, knowingly facilitate,
knowingly encourage or continue any discussions or negotiations with, or knowingly encourage or respond to any inquiries or proposals
by, or participate in any negotiations with, or provide any information to, or otherwise cooperate in any way with, any person
or other entity or “group” within the meaning of Section 13(d) of the Exchange Act, concerning any sale of any material
assets of the Company or any of the outstanding capital stock of the Company or any conversion (other than the Conversion), consolidation,
merger, business combination, liquidation, dissolution or similar transaction involving the Company or any of the Company Subsidiaries
other than with Acquiror and its Representatives (an “Alternative Transaction”), (2) amend or grant any
waiver or release under any standstill or similar agreement to which such Written Consent Party is a party with respect to any
class of equity securities of the Company or any of the Company Subsidiaries, (3) approve, endorse or recommend, or propose publicly
to approve, endorse or recommend, any Alternative Transaction, (4) approve, endorse, recommend, execute or enter into any agreement
in principle, confidentiality agreement, letter of intent, memorandum of understanding, term sheet, acquisition agreement, merger
agreement, option agreement, joint venture agreement, partnership agreement or other written arrangement relating to any Alternative
Transaction or any proposal or offer that could reasonably be expected to lead to an Alternative Transaction, (5) commence, continue
or renew any due diligence investigation regarding any Alternative Transaction, or (6) resolve or agree to do any of the foregoing
or otherwise authorize or permit any of its Affiliates or Representatives acting on its behalf to take any such action. Each Written
Consent Party shall, and shall cause its Affiliates and Representatives to, immediately cease any and all existing discussions
or negotiations with any person conducted heretofore with respect to any Alternative Transaction. Each Written Consent Party also
agrees that it will promptly request each person (other than the parties hereto and their respective Representatives) that has
prior to the date hereof executed a confidentiality agreement to which such Written Consent Party is a party in connection with
its consideration of an Alternative Transaction to return or destroy all confidential information furnished to such person by or
on behalf of it pursuant to such agreement prior to the date hereof.

 

    7

     

    

 

9.2 From
the date of this Agreement and ending on the Expiration Time, each Written Consent Party shall notify Acquiror promptly (but in
no event later than twenty-four (24) hours) after receipt by such Written Consent Party or any of its Representatives of any inquiry
or proposal with respect to an Alternative Transaction, any inquiry that would reasonably be expected to lead to an Alternative
Transaction or any request for non-public information relating to the Company or any of the Company Subsidiaries or for access
to the business, properties, assets, personnel, books or records of the Company or any of the Company Subsidiaries by any third
party, in each case, that is related to an inquiry or proposal with respect to an Alternative Transaction. In such notice, such
Written Consent Party shall, to the extent not prohibited by the terms of any confidentiality obligations existing as of the date
hereof, identify the third party making any such inquiry, proposal, indication or request with respect to an Alternative Transaction
and shall provide the details of the material terms and conditions of any such inquiry, proposal, indication or request. Each Written
Consent Party shall keep Acquiror informed, on a reasonably current and prompt basis, of the status and material terms of any such
inquiry, proposal, indication or request with respect to an Alternative Transaction, including the material terms and conditions
thereof any material amendments or proposed amendments.

 

9.3 If
any Written Consent Party or any of its Representatives receives any inquiry or proposal with respect to an Alternative Transaction
at any time prior to the Expiration Time, then such Written Consent Party shall promptly (and in no event later than twenty-four
(24) hours after the Company becomes aware of such inquiry or proposal) notify such person in writing that such Written Consent
Party is subject to an exclusivity agreement with respect to the Alternative Transaction that prohibits them from considering such
inquiry or proposal. Without limiting the foregoing, the parties agree that any violation of the restrictions set forth in this
Section 9 by a Written Consent Party or its Affiliates or Representatives shall be deemed to be a breach of this Section 9 by such
Written Consent Party.

 

10. Miscellaneous.

 

10.1 Severability.
If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of law, or public
policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the
economic or legal substance of the Agreement is not affected in any manner materially adverse to any party. Upon such determination
that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good
faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable
manner in order that the transactions be consummated as originally contemplated to the fullest extent possible.

 

    8

     

    

 

10.2 Non-survival
of Representations and Warranties. None of the representations, warranties, covenants or agreements in this Agreement or in
any schedule, instrument or other document delivered pursuant to this Agreement shall survive the Expiration Time. Notwithstanding
the foregoing, this Section 10.2 shall not limit any covenant or agreement contained in this Agreement that by its
terms is to be performed in whole or in part after the Expiration Time.

 

10.3 Assignment.
No party hereto may assign, directly or indirectly, including by operation of Law, either this Agreement or any of its rights,
interests or obligations hereunder without the prior written approval of the other parties hereto, except with respect to a Transfer
completed in accordance with Section 2.1. Subject to the first sentence of this Section 10.3, this Agreement
shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and permitted assigns.
Any assignment in violation of this Section 10.3 shall be void.

 

10.4 Amendments
and Modifications. This Agreement may be amended by the parties hereto at any time by execution of an instrument in writing
signed on behalf of each of the parties hereto.

 

10.5 Specific
Performance. The parties hereto agree that irreparable damage would occur if any provision of this Agreement were not performed
in accordance with the terms hereof, and, accordingly, that the parties shall be entitled to an injunction or injunctions to prevent
breaches of this Agreement or to enforce specifically the performance of the terms and provisions hereof in the Court of Chancery
of the State of Delaware, County of Newcastle, or, if that court does not have jurisdiction, any court of the United States located
in the State of Delaware without proof of actual damages or otherwise, in addition to any other remedy to which they are entitled
at Law or in equity as expressly permitted in this Agreement. Each of the parties hereby further waives (1) any defense in any
action for specific performance that a remedy at Law would be adequate and (2) any requirement under any Law to post security or
a bond as a prerequisite to obtaining equitable relief.

 

10.6 Notices.
All notices, requests, claims, demands and other communications hereunder shall be in writing and shall be given (and shall be
deemed to have been duly given upon receipt) by delivery in person, by email or by registered or certified mail (postage prepaid,
return receipt requested) to the respective parties at the following addresses (or at such other address for a party as shall be
specified in a notice given in accordance with this Section 10.6):

 

(i) if
to Acquiror, to:

 

Tortoise Acquisition Corp. II

5100 W. 1115th Place

Leawood, KS 66211

Attention: Vincent T. Cubbage; Steven C. Schnitzer

Email: vcubbage@tortoiseecofin.com; sschnitzer@tortoiseecofin.com

 

    9

     

    

 

with a copy (which shall not constitute notice) to:

 

Vinson & Elkins L.L.P.

1114 Avenue of the Americas

32nd Floor

New York, NY 10036

Attention: Brenda Lenahan; Ramey Layne

Email: blenahan@velaw.com; rlayne@velaw.com

 

(ii) if
to a Written Consent Party, to the address for notice set forth opposite such Written Consent Party’s name on Schedule A
hereto,

 

with a copy (which shall not constitute notice) to:

 

Volta Industries, Inc.

155 De Haro Street

San Francisco, CA 94103

Attn: James DeGraw

Email: legal@voltacharging.com

 

and

 

Orrick, Herrington & Sutcliffe LLP

The Orrick Building

405 Howard Street

San Francisco, CA 94105

Attention: Amanda Galton; Hari Raman; Albert Vanderlaan

Email: agalton@orrick.com; hraman@orrick.com; avanderlaan@orrick.com

 

10.7 Governing
Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware applicable to
contracts executed in and to be performed in that State. All legal actions and proceedings arising out of or relating to this Agreement
shall be heard and determined exclusively in any Delaware Chancery Court; provided, that if jurisdiction is not then available
in the Delaware Chancery Court, then any such legal Action may be brought in any federal court located in the State of Delaware
or any other Delaware state court. The parties hereto hereby (a) irrevocably submit to the exclusive jurisdiction of the aforesaid
courts for themselves and with respect to their respective properties for the purpose of any Action arising out of or relating
to this Agreement brought by any party hereto, and (b) agree not to commence any Action relating thereto except in the courts described
above in Delaware, other than Actions in any court of competent jurisdiction to enforce any judgment, decree or award rendered
by any such court in Delaware as described herein. Each of the parties further agrees that notice as provided herein shall constitute
sufficient service of process and the parties further waive any argument that such service is insufficient. Each of the parties
hereby irrevocably and unconditionally waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise,
in any Action arising out of or relating to this Agreement or the transactions contemplated hereby, (a) any claim that it is not
personally subject to the jurisdiction of the courts in Delaware as described herein for any reason, (b) that it or its property
is exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service
of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (c)
that (i) the Action in any such court is brought in an inconvenient forum, (ii) the venue of such Action is improper or (iii) this
Agreement, or the subject matter hereof, may not be enforced in or by such courts.

 

    10

     

    

 

10.8 WAIVER
OF JURY TRIAL. Each of the parties hereto hereby waives to the fullest extent permitted
by applicable Law any right it may have to a trial by jury with respect to any litigation directly or indirectly arising out of,
under or in connection with this Agreement or the Transactions CONTEMPLATED HEREBY. Each of the parties hereto (a) certifies that
no representative, agent or attorney of any other party has represented, expressly or otherwise, that such other party would not,
in the event of litigation, seek to enforce that foregoing waiver and (b) acknowledges that it and the other PARTIES hereto have
been induced to enter into this Agreement and the Transactions CONTEMPLATED HEREBY, as applicable, by, among other things, the
mutual waivers and certifications in this Section 10.8.

 

10.9 Entire
Agreement; Third-Party Beneficiaries. This Agreement constitutes the entire agreement among the parties hereto with respect
to the subject matter hereof and supersedes all prior agreements and understandings, both written and oral, among the parties hereto
with respect to the subject matter hereof, and is not intended to confer upon any other Person other than the parties hereto any
rights or remedies; provided, however, that the Company is an express third party beneficiary of this Agreement.

 

10.10 Counterparts.
This Agreement may be executed and delivered (including by facsimile or portable document format (pdf) transmission) in one or
more counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to
be an original but all of which taken together shall constitute one and the same agreement.

 

10.11 Headings.
The descriptive headings contained in this Agreement are included for convenience of reference only and shall not affect in any
way the meaning or interpretation of this Agreement.

 

10.12 Legal
Representation. Each of the parties hereto agrees that it has been represented by independent counsel of its choice during
the negotiation and execution of this Agreement and each party hereto and its counsel cooperated in the drafting and preparation
of this Agreement and the documents referred to herein and, therefore, waive the application of any Law, regulation, holding or
rule of construction providing that ambiguities in an agreement or other document will be construed against the party hereto drafting
such agreement or document. Each Written Consent Party acknowledges that Orrick, Herington & Sutcliffe LLP is acting as counsel
to the Company in connection with the Business Combination Agreement and the Transactions, and is not acting as counsel to any
Written Consent Party.

 

10.13 Expenses.
Except as otherwise set forth in this Agreement, all fees and expenses incurred in connection with this Agreement and the transactions
contemplated hereby shall be paid by the party hereto incurring such expenses.

 

    11

     

    

 

10.14 Further
Assurances. At the request of Acquiror or the Company, in the case of any Written Consent Party, or at the request of any Written
Consent Party, in the case of Acquiror, and without further consideration, each party shall execute and deliver or cause to be
executed and delivered such additional documents and instruments and take such further action as may be reasonably necessary to
consummate the transactions contemplated by this Agreement.

 

10.15 Waiver.
No failure or delay on the part of either party to exercise any power, right, privilege or remedy under this Agreement shall operate
as a waiver of such power, right, privilege or remedy; and no single or partial exercise of any such power, right, privilege or
remedy shall preclude any other or further exercise thereof or of any other power, right, privilege or remedy. Neither party shall
be deemed to have waived any claim available to such party arising out of this Agreement, or any power, right, privilege or remedy
under this Agreement, unless the waiver of such claim, power, right, privilege or remedy is expressly set forth in a written instrument
duly executed and delivered on behalf of such waiving party; and any such waiver shall not be applicable or have any effect except
in the specific instance in which it is given.

 

10.16 Several
Liability. The liability of any Written Consent Party hereunder is several (and not joint). Notwithstanding any other provision
of this Agreement, in no event will any Written Consent Party be liable for any other Written Consent Party’s breach of such
other Written Consent Party’s representations, warranties, covenants, or agreements contained in this Agreement.

 

10.17 No
Recourse. Notwithstanding anything to the contrary contained herein
or otherwise, but without limiting any provision in the Business Combination Agreement, this Agreement may only be enforced against,
and any claims or causes of action that may be based upon, arise out of or relate to this Agreement, or the negotiation, execution
or performance of this Agreement or the transactions contemplated hereby, may only be made against the entities and Persons that
are expressly identified as parties to this Agreement in their capacities as such and no former, current or future stockholders,
equity holders, controlling persons, directors, officers, employees, general or limited partners, members, managers, agents or
affiliates of any party hereto, or any former, current or future direct or indirect stockholder, equity holder, controlling person,
director, officer, employee, general or limited partner, member, manager, agent or affiliate of any of the foregoing (each, a “Non-Recourse
Party”) shall have any liability for any obligations or liabilities of the parties to this Agreement or for any claim
(whether in tort, contract or otherwise) based on, in respect of, or by reason of, the transactions contemplated hereby or in respect
of any oral representations made or alleged to be made in connection herewith. Without limiting the rights of any party against
the other parties hereto, in no event shall any party or any of its affiliates seek to enforce this Agreement against, make any
claims for breach of this Agreement against, or seek to recover monetary damages from, any Non-Recourse Party.

 

[Signature pages follow.]

 

    12

     

    

 

In witness whereof,
the parties hereto have caused this Agreement to be executed as of the date first set forth above.

 

	 	TORTOISE ACQUISITION CORP. II
	 	 	 
	 	By:	 /s/ Vincent T. Cubbage      
	 	Name:	Vincent T. Cubbage
	 	Title:	Chief Executive Officer and President

 

Signature
Page to

Stockholder
Support Agreement

 

    13

     

    

 

In witness whereof,
the parties hereto have caused this Agreement to be executed as of the date first set forth above.

 

	 	WRITTEN CONSENT PARTIES:
	 	 
	 	19Y VENTURES VI, LLC
	 	 
	 	By: 19Y Ventures Management, LLC 
	 	Its: Manager
	 	 	 
	 	By:	/s/ Martin Lauber
	 	Name:	Martin Lauber
	 	Title:	Managing Member
	 	 
	 	Address:
	 	120 Gilmartin Drive, Tiburon, CA 94920 
	 	 
	 	Email: mlauber@19york.com
	 	 
	 	19Y VENTURES VI-2, LLC
	 	 
	 	By: 19Y Ventures Management, LLC
	 	Its: Manager
	 	 	 
	 	By:	/s/ Martin Lauber
	 	Name:	Martin Lauber 
	 	Title:	Managing Member
	 	 	 
	 	Address:
	 	120 Gilmartin Drive, Tiburon, CA 94920 
	 	 
	 	Email: mlauber@19york.com

 

SIGNATURE PAGE TO

STOCKHOLDER SUPPORT AGREEMENT

 

    14

     

    

 

In witness whereof,
the parties hereto have caused this Agreement to be executed as of the date first set forth above.

 

	 	WRITTEN CONSENT PARTIES:
	 	 
	 	ACTIVATE CAPITAL PARTNERS, LP
	 	 
	 	By: AGC Partners GP, LP 
	 	Its: General Partner
	 	 
	 	By: AGC Partners GP, LLC 
	 	Its: General Partner
	 	 	 
	 	By:	/s/ Anup Jacob
	 	Name: 	Anup Jacob
	 	Title: 	Managing Director
	 	 
	 	Address:
	 	50 California Street, Suite 680 

San Francisco, CA 94111

Email: anup@activatecp.com

 

SIGNATURE PAGE TO

STOCKHOLDER SUPPORT AGREEMENT

 

    15

     

    

 

In witness whereof,
the parties hereto have caused this Agreement to be executed as of the date first set forth above.

 

	 	WRITTEN CONSENT PARTIES:
	 	 
	 	/s/ Andrew Lipsher
	 	Andrew Lipsher
	 	 
	 	LITTLE ROSE PARTNERS LLC
	 	 
	 	/s/ Andrew Lipsher
	 	Name: Andrew Lipsher 
	 	Title: Managing Member

 

SIGNATURE PAGE TO

STOCKHOLDER SUPPORT AGREEMENT

 

    16

     

    

 

In witness whereof,
the parties hereto have caused this Agreement to be executed as of the date first set forth above.

 

	 	WRITTEN CONSENT PARTIES: 
	 	 
	 	AUTOTECH FUND I, LP
	 	 	 
	 	By: 	/s/ Quin Garcia
	 	Name:  	Quin Garcia
	 	Title:	Managing Director
	 	 	 
	 	 	 
	 	 

 

SIGNATURE
PAGE TO

STOCKHOLDER SUPPORT AGREEMENT

 

    17

     

    

 

In witness whereof,
the parties hereto have caused this Agreement to be executed as of the date first set forth above.

 

	 	WRITTEN CONSENT PARTIES:
	 	 
	 	/s/ Christopher Wendel
	 	Christopher Wendel
	 	 
	 	BAUER FAMILY INVESTMENTS LLC
	 	 	 
	 	By:	/s/ Chris Wendel
	 	Name: 	Chris Wendel
	 	Title: 	Manager
	 	 
	 	Address:
	 	1165 Green Valley Rd. 
	 	Napa, CA 94558

 

SIGNATURE PAGE TO

STOCKHOLDER SUPPORT AGREEMENT

 

    18

     

    

 

In witness whereof,
the parties hereto have caused this Agreement to be executed as of the date first set forth above.

 

	 	WRITTEN CONSENT PARTIES:
	 	 
	 	BONITA K. COLEMAN LIVING TRUST
	 	 	 
	 	By:	/s/ Bonita C. Stewart
	 	Name: 	Bonita C. Stewart
	 	Title: 	Trustee
	 	 
	 	Address:
	 	218 West Palisade Avenue,

PO Box 5387
	 	Englewood, NJ 07631

 

SIGNATURE PAGE TO

STOCKHOLDER SUPPORT AGREEMENT

 

    19

     

    

 

In witness whereof,
the parties hereto have caused this Agreement to be executed as of the date first set forth above.

 

	 	WRITTEN CONSENT PARTIES:
	 	 
	 	/s/ Debra Crow
	 	Debra Crow

 

SIGNATURE PAGE TO

STOCKHOLDER SUPPORT AGREEMENT

 

    20

     

    

 

In witness whereof,
the parties hereto have caused this Agreement to be executed as of the date first set forth above.

 

	 	WRITTEN CONSENT PARTIES: 
	 	 
	 	ENERGIZE VENTURES FUND LP
	 	 	 
	 	By:	/s/ John Tough
	 	Name: 	John Tough
	 	Title: 	Senior Partner
	 	 
	 	Address:
	 	1 South Wacker Dr., Suite 1620 

Chicago, IL 60606
	 	 
	 	EV VOLTA SPV LLC
	 	 
	 	By: Energize Ventures GP LLC
	 	 
	 	/s/ John Tough
	 	Name: 	John Tough
	 	Title: 	Managing Partner
	 	 
	 	Address:
	 	 
	 	1 South Wacker Dr., Suite 1620

Chicago, IL 60606
	 	 
	 	Email: john@energize.vc

 

SIGNATURE PAGE TO

STOCKHOLDER SUPPORT AGREEMENT

 

    21

     

    

 

In witness whereof,
the parties hereto have caused this Agreement to be executed as of the date first set forth above.

 

	 	WRITTEN CONSENT PARTIES: 
	 	 
	 	EPIC VENTURE FUND IV, LLC
	 	 	 
	 	By:	/s/ Kent Madsen
	 	Name: 	Kent Madsen
	 	Title: 	Manager
	 	 
	 	Address:
	 	1338 Foothill Drive #282 

Salt Lake City, UT 84108
	 	 
	 	Email: kmadsen@epicvc.com

 

SIGNATURE PAGE TO

STOCKHOLDER SUPPORT AGREEMENT

 

    22

     

    

 

In witness whereof,
the parties hereto have caused this Agreement to be executed as of the date first set forth above.

 

	 	WRITTEN CONSENT PARTIES:
	 	 
	 	FOUNDRY SQUARE INVESTORS - XX, LLC
	 	 	 
	 	By:	/s/ Amanda Galton
	 	Name: 	Amanda Galton
	 	Title: 	Authorized Representative
	 	 
	 	Address:
	 	405 Howard Street
	 	San Francisco, CA 94105

 

SIGNATURE PAGE TO

STOCKHOLDER SUPPORT AGREEMENT

 

    23

     

    

 

In witness whereof,
the parties hereto have caused this Agreement to be executed as of the date first set forth above.

 

	 	WRITTEN CONSENT PARTIES:
	 	 
	 	/s/ James Degraw
	 	James Degraw

 

SIGNATURE PAGE TO

STOCKHOLDER SUPPORT AGREEMENT

 

    24

     

    

 

In witness whereof, the parties hereto have
caused this Agreement to be executed as of the date first set forth above.

 

	 	WRITTEN CONSENT PARTIES:
	 	 
	 	NAUTILUS VENTURE PARTNERS FUND I, L.P.
	 	 	 
	 	By:	/s/ Brian Kang
	 	Name: 	Brian Kang
	 	Title: 	Managing Director

 

SIGNATURE PAGE TO

STOCKHOLDER SUPPORT AGREEMENT

 

    25

     

    

 

In witness whereof,
the parties hereto have caused this Agreement to be executed as of the date first set forth above.

 

	 	WRITTEN CONSENT PARTIES:
	 	 
	 	Pacific Premier Trust Custodian FBO Eli Aheto IRA
	 	 
	 	By:	/s/ Eli Aheto
	 	Name: 	Eli Aheto
	 	Title:	 

 

SIGNATURE PAGE TO

STOCKHOLDER SUPPORT AGREEMENT

 

    26

     

    

 

In witness whereof,
the parties hereto have caused this Agreement to be executed as of the date first set forth above.

 

	 	WRITTEN CONSENT PARTIES:
	 	 
	 	PRINCEVILLE CLIMATE EV CHARGING INVESTMENTS LIMITED
	 	 	 
	 	By:	/s/ Joaquin Rodriguez Torres
	 	Name: 	Joaquin Rodriguez Torres
	 	Title: 	Director
	 	 
	 	Address:
	 	c/o Princeville Capital, 101 Natoma St., 2F

San Francisco, CA 94105
	 	 
	 	Email: joaquin@pvglobal.com

 

SIGNATURE PAGE TO

STOCKHOLDER SUPPORT AGREEMENT

 

    27

     

    

 

In witness whereof,
the parties hereto have caused this Agreement to be executed as of the date first set forth above.

 

	 	WRITTEN CONSENT PARTIES:
	 	 
	 	/s/ Scott Mercer
	 	Scott Mercer

 

SIGNATURE PAGE TO

STOCKHOLDER SUPPORT AGREEMENT

 

    28

     

    

 

In witness whereof,
the parties hereto have caused this Agreement to be executed as of the date first set forth above.

 

	 	WRITTEN CONSENT PARTIES: 
	 	 
	 	VIRGO HERMES, LLC
	 	 	 
	 	By:	/s/ Jesse Watson
	 	Name: 	Jesse Watson
	 	Title: 	Founder & CIO
	 	 
	 	Address:
	 	1201 Howard Avenue

Burlingame, CA 94010
	 	 
	 	Email: jwatson@virgo-llc.com

 

SIGNATURE PAGE TO

STOCKHOLDER SUPPORT AGREEMENT

 

    29

     

    

 

In witness whereof,
the parties hereto have caused this Agreement to be executed as of the date first set forth above.

 

	 	WRITTEN CONSENT PARTIES:
	 	 
	 	WALDEN RIVERWOOD VENTURES, L.P.
	 	 	 
	 	By: 	Walden Riverwood Ventures GP, LLC,

 its General Partner
	 	 	 
	 	By:	/s/ Andrew Kau
	 	Name: 	Andrew Kau
	 	Title: 	Partner
	 	 
	 	Address:
	 	1 California St #1750

San Francisco, CA 94111
	 	 
	 	Email: akau@waldenintl.com

 

SIGNATURE PAGE TO

STOCKHOLDER SUPPORT AGREEMENT

    30

     

    

 

In witness whereof,
the parties hereto have caused this Agreement to be executed as of the date first set forth above.

 

	 	WRITTEN CONSENT PARTIES:
	 	 
	 	YIELD CAPITAL PARTNERS VII, L.P
	 	 	 
	 	By: 	Yield Capital Partners VII GP, LLC, 

its general partner
	 	 	 
	 	By:	/s/ Jon Ylvisaker
	 	Name: 	Jon Ylvisaker
	 	Title: 	Managing Member
	 	 
	 	Address:
	 	400 Park Avenue, 21st Floor

New York, NY 10022
	 	 
	 	Email: jon@yieldcapitalpartners.com

 

SIGNATURE PAGE TO

STOCKHOLDER SUPPORT AGREEMENT

 

    31

     

    

 

Schedule A

 

	Written Consent
    Party	 	Address for
    Notice	 	Shares
    of Company Class A Common Stock	 	 	Shares
    of Company Class B Common Stock	 	 	Shares
    of Company Series A Preferred Stock	 	 	Shares
    of Company Series B Preferred Stock	 	 	Shares
    of Company Series C Preferred Stock	 	 	Shares
    of Company Series C-1 Preferred Stock	 	 	Shares
    of Company Series C-2 Preferred Stock	 	 	Shares
    of Company Series D Preferred Stock	 	 	Shares
    of Company Series D-1 Preferred Stock	 	 	Company
    Warrants	 	 	Company
    Options	 	 	Company
    Non-Plan

    Options	 	 	Company
    Restricted Stock	 
	19Y Ventures VI, LLC	 	120 Gilmartin Drive
 Tiburon, CA 94920	 	 	 	 	 	 	285,229	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	       	 	 	 	 	 	 	 	135,484	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	      	 	 	 	 	 
	19Y Ventures VI-2, LLC	 	120 Gilmartin Drive
 Tiburon, CA 94920	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	677,424	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Activate Capital Partners, LP	 	50 California Street, Suite 680
 San Francisco, CA 94111	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	4,173,373	 	 	 	 	 	 	 	767,579	 	 	 	 	 	 	 	412,073	 	 	 	165,000	 	 	 	 	 	 	 	 	 	 	 	 	 
	Andrew Lipsher	 	21 East 90th Street, Apartment 7A
 New York, NY 10128
 USA	 	 	177,266	 	 	 	1,586,328	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	351,928	 	 	 	 	 	 	 	711,328	 
	AutoTech Fund I, LP	 	525 Middlefield Road Suite 130
 Menlo Park, CA 94025	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1,324,645	 	 	 	894,294	 	 	 	 	 	 	 	959,479	 	 	 	 	 	 	 	561,204	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Bauer Family Investments LLC	 	1165 Green Valley Road
 Napa, CA 94558	 	 	 	 	 	 	 	 	 	 	60,461	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	54,249	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Bonita K Coleman Living Trust	 	218 West Palisade Avenue, PO Box 5387
 Englewood, NJ 07631	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	54,377	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Christopher Wendel	 	1165 Green Valley Road
 Napa, CA 94558
 USA	 	 	1,947,910	 	 	 	5,516,937	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1,661,028	 
	Debra Crow	 	1617 Seaborn Court
 Alameda, CA 94501
 USA	 	 	57,182	 	 	 	966,309	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	27,142	 	 	 	 	 	 	 	140,000	 	 	 	 	 	 	 	520,983	 
	Energize Ventures Fund LP	 	1 South Wacker Drive Suite 1620
 Chicago, IL 60606	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	4,173,374	 	 	 	 	 	 	 	1,918,949	 	 	 	 	 	 	 	841,806	 	 	 	546,679	 	 	 	 	 	 	 	 	 	 	 	 	 
	EPIC Venture Fund IV. LLC	 	1338 Foothill Drive #282
 Salt Lake City, UT 84108	 	 	 	 	 	 	 	 	 	 	648,368	 	 	 	333,530	 	 	 	268,288	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

 

Schedule A

 

     

     

    

 

	EV Volta SPV LLC	 	1 South Wacker Drive, Suite 1620
 Chicago, IL 60606	 	 	 	 	 	 	570,459	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	383,790	 	 	 	569,036	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	            	 	 	 	 	 
	Foundry Square Investors - XX, LLC	 	405 Howard Street
 San Francisco, CA 94105	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	27,310	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Hudson Bay Master Fund Ltd.	 	777 Third Avenue, 30th Floor
 New York, NY 10017	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1,354,848	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	James DeGraw	 	937 Clayton St.
 San Francisco, CA 94117
 USA	 	 	 	 	 	 	449,665	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	200,000	 	 	 	 	 	 	 	262,165	 
	Little Rose Partners LLC	 	21 E. 90th Street
 New York, NY 10128
 USA	 	 	 	 	 	 	 	 	 	 	 	 	 	 	71,602	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Nautilus Venture Partners Fund I, L.P.	 	575 High St. #330
 Palo Alto, CA 94301	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1,788,588	 	 	 	 	 	 	 	767,579	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Pacific Premier Trust Custodian FBO Eli Aheto IRA	 	78 Sullivan St
 Brooklyn, NY 11231	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	34,001	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Princeville Climate EV Charging Investments Limited	 	c/o Princeville Capital
 101 Natoma St. 2F
 San Francisco,
    CA 94105	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1,628,892	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Scott Mercer	 	155 De Haro St
 San Francisco, CA 94103
 USA	 	 	5,954,535	 	 	 	4,864,249	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	543,308	 	 	 	 	 	 	 	712,972	 
	Virgo Hermes, LLC	 	1201 Howard Avenue
 Burlingame, CA 94010	 	 	 	 	 	 	 	 	 	 	 	 	 	 	3,580,123	 	 	 	894,294	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1,386,686	 	 	 	7,507,575	 	 	 	 	 	 	 	 	 	 	 	 	 
	Walden Riverwood Ventures, L.P.	 	1 California St. #1750
 San Francisco, CA 94111	 	 	 	 	 	 	 	 	 	 	1,042,213	 	 	 	1,286,523	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Yield Capital Partners VII, L.P.	 	400 Park Avenue, 21st Floor, New York, NY 10022	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	1,595,333	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

 

Schedule A

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}]]